Active Biotech
focuses on developing pharmaceuticals products for immune defense... Read moreActive Biotech
focuses on developing pharmaceuticals products for immune defense... Read more
President & CEO
Tomas Leanderson
Annual Revenue
$ < 1M
Employees
17
News
Nov 25, 2024
FinanzNachrichten
Active Biotech: Nasdaq Stockholm AB: New last trading day for paid subscription shares (BTA) of Active Biotech rights issue
Aug 23, 2024
Marketscreener
Active Biotech: Active Biotech Q2 2024 - Both Myelofibrosis Studies Soon Recruiting
Aug 22, 2024
Marketscreener
Active Biotech: Active Biotech AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
May 13, 2024
MarketScreener
Active Biotech: Active Biotech : Interview with Prof. Dr. Axel Glasmacher, Independent Board Member at Active Biotech
May 08, 2024
Marketscreener
Active Biotech: Active Biotech AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Jan 03, 2024
Global Legal Chronicle
Active Biotech: Active Biotech's Rights Offering
Aug 24, 2023
Marketscreener
Active Biotech: Active Biotech AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Jul 31, 2023
Marketscreener
Active Biotech: Active Biotech AB Enters into Clinical Trial Collaboration Agreement for a Clinical Study with Tasquinimod in Myelofibrosis
Sep 15, 2022
FinanzNachrichten
Active Biotech: Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of Active Biotech AB (142/22)
Aug 09, 2022
Global Legal Chronicle
Active Biotech: Active Biotech's SEK 55 Million Rights Offering
Active Biotech Competitors
1
2
3
4
5
6
7
8
9
10